0

Vaccines/Immunization Collection
 41-60 of 245 Articles
Reviews |  18 March 2003 FREE
Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options
J. Michael Lane, MD, MPH; Joel Goldstein, MD
Ann Intern Med. 2003;138(6):488-493. doi:10.7326/0003-4819-138-6-200303180-00014
Articles |  20 August 2002
Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults
Patrick Y. Lee, MD; David B. Matchar, MD; Dennis A. Clements, MD, PhD; et al.
Ann Intern Med. 2002;137(4):225-231. doi:10.7326/0003-4819-137-4-200208200-00005
Therapeutics |  May/Jun 2002
Review: Inactivated vaccines provide the greatest protection against influenza in healthy persons
Peter A. Gross, MD
Ann Intern Med. 2002;136(3):103. doi:10.7326/ACPJC-2002-136-3-103
Position Papers |  1 January 2002
Pharmacist Scope of Practice
American College of Physicians–American Society of Internal Medicine*
Ann Intern Med. 2002;136(1):79-85. doi:10.7326/0003-4819-136-1-200201010-00014
Brief Communications |  6 November 2001
Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination
Yen-Hsuan Ni, MD, PhD; Mei-Hwei Chang, MD; Li-Min Huang, MD, PhD; et al.
Ann Intern Med. 2001;135(9):796-800. doi:10.7326/0003-4819-135-9-200111060-00009
Editorials |  6 November 2001 FREE
Protecting Future Generations through Immunization against Hepatitis B
Miriam J. Alter, PhD
Ann Intern Med. 2001;135(9):835-836. doi:10.7326/0003-4819-135-9-200111060-00013
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001 FREE
Quality Indicators for the Management of Pneumonia in Vulnerable Elders
David C. Rhew, MD
Ann Intern Med. 2001;135(8_Part_2):736-743. doi:10.7326/0003-4819-135-8_Part_2-200110161-00013
Current Clinical Issues |  17 October 2000
Vaccines Today
Aaron Levin
Ann Intern Med. 2000;133(8):661. doi:10.7326/0003-4819-133-8-200010170-00102
Current Clinical Issues |  19 September 2000
HIV Vaccines: Inch by Inch
Brigid Kane
Ann Intern Med. 2000;133(6):489-490. doi:10.7326/0003-4819-133-6-200009190-00102
Reviews |  18 April 2000
The Lyme Disease Vaccine: Conception, Development, and Implementation
Wendy Todaro Thanassi, MA, MD; Robert T. Schoen, MD
Ann Intern Med. 2000;132(8):661-668. doi:10.7326/0003-4819-132-8-200004180-00009
Brief Communications |  21 September 1999 FREE
Efficacy of Influenza Vaccination in HIV-Infected Persons: A Randomized, Double-Blind, Placebo-Controlled Trial
Sybil A. Tasker, MD; John J. Treanor, MD; William B. Paxton, MD, PhD; et al.
Ann Intern Med. 1999;131(6):430-433. doi:10.7326/0003-4819-131-6-199909210-00006
Articles |  2 March 1999
Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease
Kristin L. Nichol, MD, MPH; Leslie Baken, MD; Andrew Nelson, MPH
Ann Intern Med. 1999;130(5):397-403. doi:10.7326/0003-4819-130-5-199903020-00003
Currents |  16 February 1999
Putting Prevention into Practice: The Community's Role
Tom Reynolds
Ann Intern Med. 1999;130(4_Part_1):336. doi:10.7326/0003-4819-130-4-199902160-00011
Editorials |  1 October 1998
Lyme Disease Vaccines
Pierce Gardner, MD
Ann Intern Med. 1998;129(7):583-585. doi:10.7326/0003-4819-129-7-199810010-00015
Brief Communications |  15 July 1998
Vaccine-Associated Measles Pneumonitis in an Adult with AIDS
Jonathan B. Angel, MD; Pramila Walpita, PhD; Robert A. Lerch, PhD; et al.
Ann Intern Med. 1998;129(2):104-106. doi:10.7326/0003-4819-129-2-199807150-00007
Currents |  15 October 1997
News Notes
Ann Intern Med. 1997;127(8_Part_1):664. doi:10.7326/0003-4819-127-8_Part_1-199710150-00045
Currents |  15 September 1997
Biotechnology Creating Edible Vaccines
Cynthia Washam
Ann Intern Med. 1997;127(6):499. doi:10.7326/0003-4819-127-6-199709150-00030
Editorials |  1 September 1997
Vaccines for Tuberculosis: The Glass Remains Half Empty
Jeffrey Glassroth, MD
Ann Intern Med. 1997;127(5):403-404. doi:10.7326/0003-4819-127-5-199709010-00012
Editorials |  15 January 1997
DNA and the Immune System
David S. Pisetsky, MD, PhD
Ann Intern Med. 1997;126(2):169-171. doi:10.7326/0003-4819-126-2-199701150-00015
Articles |  15 August 1996
Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind Trial
Barney S. Graham, MD, PhD; Michael C. Keefer, MD; M. Juliana McElrath, MD, PhD; et al.
Ann Intern Med. 1996;125(4):270-279. doi:10.7326/0003-4819-125-4-199608150-00003
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)